The Goldman Sachs Group vs AbbVie Inc.
Side-by-side earnings signal comparison from SEC quarterly filings
Verdict
The Goldman Sachs Group (GS) carries a "Neutral" signal with -3.8% revenue growth, while AbbVie Inc. (ABBV) is "Tailwind" with +10.0% revenue growth. Both companies report in the Financials and Healthcare sectors.
| Metric | The Goldman Sachs Group (GS) | AbbVie Inc. (ABBV) |
|---|---|---|
| Operator Signal | Neutral | Tailwind |
| Signal Confidence | HIGH | HIGH |
| Latest Revenue | $20.6B | $16.6B |
| Revenue Growth | -3.8% | 10.0%* |
| Latest EPS | $17.55* | $1.02 |
| EPS Growth | 108.9% | N/A |
| Sector | Financials | Healthcare |
| Quarters Tracked | 8 | 8 |
The Goldman Sachs Group (GS) carries a "Neutral" signal with -3.8% revenue growth, while AbbVie Inc. (ABBV) is "Tailwind" with +10.0% revenue growth. Both companies report in the Financials and Healthcare sectors.